BIOMAT Database Logo BIOMAT Database Logo

[The study on the platelet aggregation inhibition activity of placental brush border (the mechanism of platelet aggregation inhibition)]. 1989

H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Department of Obstetrics and Gynecology, Nara Medical University.

To clarify the role of placental brush border in the regulation of placental microcirculation, we investigated the platelet aggregation inhibition activity of placental brush border membrane vesicles (BBMV) and obtained the following results. 1. There was very strong platelet aggregation inhibiting activity in placental BBMV. In the 20-40 micrograms/ml protein concentration, the BBMV almost completely inhibited the platelet aggregation induced by ADP, arachidonic acid and collagen, and in the 100-150 micrograms/ml protein concentration, the BBMV almost completely inhibited the platelet aggregation induced by ristocetin. 2. There existed a very strong ADP degrading activity (ADPase activity) in the placental BBMV. The platelet aggregation activity of ADP was completely lost when ADP was preincubated with the placental BBMV. 3. The placental BBMV inhibited platelet malondialdehyde (MDA) production. With the 20 micrograms/ml and 100 micrograms/ml protein concentrations of placental BBMV, 22% and 65% of platelet MDA production was inhibited respectively.

UI MeSH Term Description Entries
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008871 Microvilli Minute projections of cell membranes which greatly increase the surface area of the cell. Brush Border,Striated Border,Border, Brush,Border, Striated,Borders, Brush,Borders, Striated,Brush Borders,Microvillus,Striated Borders
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Platelet aggregation inhibiting activity of human placental chorioepithelial brush border membrane vesicles.
January 1993, Placenta,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Studies on placental inhibition of platelet aggregation: a comparison of human syncytiotrophoblast brush border and basal plasma membranes.
January 1993, Placenta,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Platelet aggregation inhibiting activity of human placental chorioepithelial brush border membrane vesicles--the role of alkaline phosphatase.
April 1994, Placenta,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
[Study on the mechanism of placental transport of phosphate (using human placental microvillous (brush border) membrane vesicles)].
December 1985, Nihon Sanka Fujinka Gakkai zasshi,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
[Study on the mechanism of placental transport of L-lysine (using human placental microvillous (brush border) membrane vesicles)].
July 1985, Nihon Sanka Fujinka Gakkai zasshi,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
[Mechanism of platelet aggregation inhibition].
January 1979, Rinsho byori. The Japanese journal of clinical pathology,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Inhibition of platelet aggregation by placental extracts.
January 1980, Thrombosis research,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Hydrolysis of nicotinamide-adenine dinucleotide by purified renal brush-border membranes. Mechanism of NAD+ inhibition of brush-border membrane phosphate-transport activity.
June 1982, The Biochemical journal,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
Sulphate transport in human placental brush-border membrane vesicles: competitive inhibition by selenate.
July 1986, Biochimica et biophysica acta,
H Iioka, and H Hisanaga, and I Moriyama, and M Akasaki, and K Nabuchi, and Y Katakami, and Y Katoh, and M Ichijo
[Placental transport of taurine in brush border microvilli].
July 1984, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!